Obinutuzumab in Rituximab-Intolerant Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients.

ABSTRACT:

SUBMITTER: van Leeuwen JR 

PROVIDER: S-EPMC12034865 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature